SGLT2 inhibitors significantly improve hemoglobin and hematocrit levels in CKD patients, enhancing anemia management. The KDIGO 2024 guideline endorses SGLT2 inhibitors for CKD patients ...

Herein, we present the case of a 91-year-old male farmer, from Amazonas, with no relevant medical or family history. He reports two weeks of asthenia and shortness of breath at moderate efforts. One ...

The goal is to lower your hematocrit level. Hematocrit is the percentage of red blood cells compared with the total amount of blood. You'll get this treatment once a week or month until your ...